Peripheral Vascular Devices Market Size, Share, Forecast Report 2026 to 2035
What is Peripheral Vascular Devices Market Size?
Global Peripheral Vascular Devices Market Size is valued at USD 11.19 Bn in 2025 and is predicted to reach USD 22.88 Bn by the year 2035 at a 7.9% CAGR during the forecast period for 2026 to 2035.
Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Product Type (Aortic Stent Grafts, Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Inferior Vena Cava Filters (IVCF)), By End-User, By Region, And By Segment Forecasts, 2026 to 2035
Peripheral Vascular Devices Market Key Takeaways:
|
Peripheral vascular disease (PVD) is caused due to accumulation of plaque within the inside lining of arteries. With the increasing age, the incidence of PVD also increases. It is more common among the diabetic and smoking population. More than 5% of the population above age 50 years suffers from PVD. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque build-up. These diseases can be treated through minimally invasive surgeries. Peripheral vascular devices are used for the treatment of these blocked arteries and to remove the build-up plaque.
Peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, and aortic stents are the most used devices for the treatment of PVD. The growth of this market is driven by factors such as rising incidences of PVD, increasing demand for minimally invasive procedures, changing lifestyles, and the global aging population. Asia is expected to be the largest market with high growth opportunities owing to rising disposable income and the high unmet medical needs of the patient population.
Market Segmentation
The peripheral vascular devices market is a segment based on product type, end-user, and geography. In terms of product type, the global market is segregated aortic stent-grafts, arteriotomy closure devices, carotid and renal artery stents, inferior vena cava filters (IVCF), peripheral embolic protection devices, peripheral guidewires, peripheral vascular stents, PTA balloons catheters, PTA peripheral drug-eluting, balloons (DEB) catheters, renal denervation catheters, tip location devices, and vascular grafts. The peripheral vascular stents market holds a major share in the total peripheral vascular devices market.
The growth of this market is justified by the increasing incidence rate of lifestyle diseases such as obesity and diabetes. The embolic protection devices market is expected to grow at the highest growth rate during the forecasted period. Technological advancements in the devices such as tracking the position during the procedure and drug-coated stents would boost the demand for these devices as it overcomes the issues faced by surgeons.
Based on end-user, the global peripheral vascular devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. PVD is a vastly under-diagnosed disease, less than 30% of the total patient population are diagnosed with PVD. Lack of awareness among patients is the main reason for the under-diagnosis of PVD. It is estimated that 20% of the total patient population have PVD, and are prone to high-risk factors such as diabetes and obesity contributors for the development of PVD. Hence, with the increasing aging population, the incidence rate of PVD would also grow to impact the growth of the market. The rising incidence rate would have a high impact on the growth of the peripheral vascular devices market throughout the forecast period.
Based on geography, the global Peripheral Vascular Devices market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, North America is estimated to account for the largest share in the global market in 2019. There is a general increase in the peripheral and lower limb procedures which would boost the market for these devices during the forecast period; more than 15% of the total aged population suffers from PAD in this region. The aging population in North America is expected to increase by around 5% every year.
However, the infections caused due to peripheral vascular implantations and surgeries would prove to be a challenge for the growth of these devices. In order to overcome these issues and meet patient's demands, manufacturers are coming up with newer and technologically advanced products which would increase the base of the treatable population. Market players such as Cordis Corporation, Boston Scientific Corporation, and Abbott Laboratories have a significant presence in the North American market.
Competitive Landscape
Some Major Key Players In The Peripheral Vascular Devices Market:
- Abbott Laboratories,
- Boston Scientific Corp,
- Biotronik,
- Bentley InnoMed GmbH,
- Cardiva Medical Inc.,
- Medtronic plc,
- L. Gore & Associates Inc,
- Avascular S.L.U,
- Cook Medical Inc,
- Terumo Corp,
- Braun Melsungen AG,
- Getinge AB,
- R. Bard Inc (BD),
- Cardinal Health Inc.,
- Cordis Corp,
- Endologix Inc,
- Terumo Medical Corporation
Peripheral Vascular Devices Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 11.19 Billion |
| Revenue Forecast In 2035 | USD 22.88 Billion |
| Growth Rate CAGR | CAGR of 7.9 % from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Billion, and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories, Boston Scientific Corp, Biotronik, Bentley InnoMed GmbH, Cardiva Medical Inc., Medtronic plc, W. L. Gore & Associates Inc, Avascular S.L.U, Cook Medical Inc, Terumo Corp, B. Braun Melsungen AG, Getinge AB, C. R. Bard Inc (BD), Cardinal Health Inc., Cordis Corp, Endologix Inc, and Terumo Medical Corporation among others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Peripheral Vascular Devices Market Segmentation
Global Peripheral Vascular Devices Market By Product Type
- Aortic Stent Grafts
- Arteriotomy Closure Devices
- Carotid and Renal Artery Stents
- Inferior Vena Cava Filters (IVCF)
- Peripheral Embolic Protection Devices
- Peripheral Guidewires, Peripheral Vascular Stents
- PTA Balloons Catheters
- PTA Peripheral Drug Eluting
- Balloons (DEB) Catheters
- Renal Denervation Catheters
- Tip Location Devices
- Vascular Grafts
Global Peripheral Vascular Devices Market By End-Users
- Hospitals
Ambulatory Care Centers
Specialty Clinics
Others
Global Peripheral Vascular Devices Market By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Medtronic plc, W. L. Gore & Associates Inc, Avascular S.L.U, Cook Medical Inc, Terumo Corp, B. Braun Melsungen AG, Getinge AB, C. R. Bard Inc (BD),
Peripheral Vascular Devices Market Size is valued at USD 11.19 Bn in 2025 and is predicted to reach USD 22.88 Bn by the year 2035.
Peripheral Vascular Devices Market is expected to grow at a 7.9 % CAGR during the forecast period for 2026-2035.
peripheral vascular devices market is a segment based on product type, end-user, and geography, inferior vena cava filters (IVCF), peripheral embolic protection devices, peripheral guidewires, peripheral vascular stents, PTA balloons catheters.
North America region is leading the Peripheral Vascular Devices Market